Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Page 2

Berkeley Lights beams on to public markets
The Nikon and Varian-backed cell biology technology developer floated in a $178m offering and its shares almost tripled in price on their first day of trading.
Pandion stands up in $135m IPO
The Roche and GSK-backed autoimmune disease drug developer has gone public in an upsized initial public offering after at least $138m in earlier funding.
Farasis carries off $486m in IPO
The EV battery producer has gone public in China, weeks after raising $193m in a round featuring strategic partner Daimler.
Relay receives $400m in initial public offering
The oncology therapy developer has gone public in an upsized offering that provided exits for SoftBank Vision Fund and Alphabet's GV unit.
Ocumension occupies listing place after $200m IPO
The ophthalmologic drug developer has gone public three years after being founded by WuXi AppTec-backed 6 Dimensions Capital.
Salesforce-backed nCino scores $250m IPO
The banking software provider's shares have nearly tripled following an offering in which it floated well above its range.
Quhuo quickens pace to $33m IPO
The Baidu and SoftBank-backed on-demand staff provider floated in the middle of its range in a US offering and its market cap currently stands at about $600m.
Blued blasts its way onto public markets
New World Development and China Mobile-backed gay social and dating app developer Blued raised $84.8m and has seen its shares nearly double in price post-IPO.
Branding Engineer marks details for Tokyo listing
The Crooz, InterWorks, MyNavi, Sega Sammy and Vector-backed IT human resources provider could raise up to $21m in its initial public offering.
Cambricon cashes $368m in initial public offering
Lenovo, iFlytek, Alibaba and Tuling Century-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

test reg